Share

FDA urges for arthritis drug approval

accreditation
Various tablets
Various tablets
istock

Tofacitinib, taken orally, could serve as an alternative approach to treating moderate to severe patients who did not respond to one or more traditional therapies such as methotrexate, said the advisory committee by a vote of 8-2.

The panel urged the drug's approval despite mixed results on its effects at different doses, and some safety concerns about the risks of cancer – mainly lymphoma – and infections.

Disease cause remains a mystery

Rheumatoid arthritis is a progressive autoimmune disease that causes debilitating joint pain that can lead to deformity, and affects about 1% of people in the United States and Europe, most of them women.

Exactly what causes the disease remains a mystery, and there is no known cure.

The FDA does not have to follow the recommendations of the advisory panel though it often does.

Read more:

Rheumatoid Arthritis

Arthritis

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE